combination therapy for cll in the captivate trial
Published 6 years ago • 60 plays • Length 2:37Download video MP4
Download video MP3
Similar videos
-
1:40
captivate and beyond: combination therapies for cll
-
11:23
captivate: fixed-duration first-line treatment with ibrutinib plus venetoclax for cll/sll
-
4:54
the captivate trial of ibrutinib and venetoclax as a first line treatment for cll patients
-
21:19
cll: sequencing monotherapy vs. combination therapy
-
9:20
triplet therapy for all comers in the cll-bag trial
-
4:04
ibrutinib plus venetoclax for the first-line treatment of cll/sll: results from the captivate study
-
1:58
dr. eradat on the captivate trial in cll
-
0:52
is there a role for combination therapy in cml?
-
2:37
captivate and innovate clinical trial results for cll
-
6:55
ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic leukaemia
-
0:57
unanswered questions in frontline cll treatment
-
10:41
captivate: first-line ibrutinib plus venetoclax for cll/sll
-
5:54
updates from captivate: ibrutinib and venetoclax for cll
-
3:49
update on the captivate study for chronic lymphocytic leukemia patients
-
2:21
captivate: ibrutinib and venetoclax in cll
-
0:59
dr. tam on results of the captivate trial in cll
-
5:27
ibrutinib as a frontline therapy in resonate2 trials for cll
-
58:11
crafting the new treatment mix in cll
-
2:17
captivate: 1-year dfs results from the mrd cohort in cll